It has been shown by Handorf et a! (1985) and Campbell et al(1986) that bromine levels are higher in patients receiving lithium; these workers considered that the effect was most likely due to lithium interfering with the renal excretion of bromine. Handorf et a! (1985) suggested that the relatively slight increase of bromine, in the subtherapeutic range, could have pharmacological effects worthy of further study. Bromine could contribute to the anti manic effect of lithium, and lithium could potentiate the sedative effects of bromine. In the present study we, therefore, assessed whether the bromine levels of lithium patients were raised, and if so whether they related to response to lithium treatment. Slightly raised levels of bromine in blood in workers using methyl bromide as a pesticide have been shown to produce electroencephalographic (EEG) abnormalities (Verberk et al, 1979) . It is well known that long-term lithium treatment produces EEG abnormalities in some patients, although it is impossible to predict those in whom they will occur. tested whether these abnormalities were contributed to by associated disturbances of trace elements. In addition to our interest in bromine, we have recently found that RBC vanadium levels appear to be raised by lithium (Harvey & Ward, 1991) . Also, some early blood results from our lithium clinic showed that the mean ratio of RBC: serum aluminium of lithium patients, whose cognition was assumed to be normal, was considerably higher than that reported in dialysis patients (Van der Voet & de Wolff, 1985), and serum aluminium has been shown to be raised in patients receiving lithium (Campbell et a!, 1989 The circumstances of the project permitted only a relatively small number of patients to be involved in what amounts to a pilot study.
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Slightly raised levels of bromine in blood in workers using methyl bromide as a pesticide have been shown to produce electroencephalographic (EEG) abnormalities (Verberk et al, 1979) . It is well known that long-term lithium treatment produces EEG abnormalities in some patients, although it is impossible to predict those in whom they will occur. Some workers have found a relationship between EEG changes and serum lithium levels (Mayfield & Brown, 1966) , but Johnson et a! (1970) found that EEG changes correlate more with lithium-induced side effects than with serum lithium levels. Zakowska Dabrowska & Rybakowski (1973) found that EEG changes tended to relate to lithium levels in red blood cells (RBCs) during established treatment. In view of the unresolved origin of EEG abnormalities associated with long-term lithium treatment, we tested whether these abnormalities were contributed to by associated disturbances of trace elements. In addition to our interest in bromine, we have recently found that RBC vanadium levels appear to be raised by lithium (Harvey & Ward, 1991) . Also, some early blood results from our lithium clinic showed that the mean ratio of RBC: serum aluminium of lithium patients, whose cognition was assumed to be normal, was considerably higher than that reported in dialysis patients (Van der Voet & de Wolff, 1985) , and serum aluminium has been shown to be raised in patients receiving lithium (Campbell et a!, 1989 The circumstances of the project permitted only a relatively small number of patients to be involved in what amounts to a pilot study.
Method
Twelvelong-termlithiumout-patientsfrom an earlierstudy were recruited to follow-up studies, including the present work.TheirDSM-III-R diagnoseswereof bipolardisorder or major depression, recurrent (American Psychiatric Association, 1987) .They werein remissionand none had alcoholproblems.In additionto lithium,two werereceiving tricycic antidepressants. Throughoutthe studyno attempts were made to influence dietary intake. Subjectsweregiventhe SymptomChecklistquestionnaire (Ghose,1977) , whichproducesa scoreconsistingof the sum of the lithium-inducedside-effects,weightedaccordingto severity.On a later visitthey wereassessedfor inteffigence (Weschler, 1981) , a blood sample was taken for lithium determination, then an EEG wasperformed,withoutphotic stimulation or over-breathing. The two patients on antidepressants had discontinued this treatment in the week before the EEG. These tests were given in the same order, in the same laboratory, and all but one were commenced at approximately 10a.m. The patients remained alert throughout the test procedures.
Bloodspecimensweretaken someweekslater for trace element analysis and haematocrit determination, at which time nine patients were still receiving lithium, one of whom Results Raised bromine levels were confirmed in the patients receiving lithium, in serum and the RBCs, without any disturbance of the RBC :serum bromine ratio (Table 1) . The aluminium levels were normal and the levels of vanadium were raised (Table 1) . Oaithersburg, USA).
The haematocrit determinations were performed on a
Coulter S Plus machine. The RBC levels of the trace elements were calculated from the serumand whole-blood levels and the haematocrit (Summerton et al, 1989) . Some of our data on the effect of lithium on trace elements, including vanadium, are published elsewhere (Harvey & Ward, 1991) .
The patients' clinical histories were obtained from their records, and any relapses in the two years following the tests were assessed prospectively.
The EEGs were analysed by a clinical neurophysiologist blind to the rest of the study (JJ). Of the nine patients receiving lithium at the time of trace-element testing, JJ identified five with prominent EEG abnor malities, including slowing of the dominant frequency, irregular delta activity, bursts of fairly rhythmic slow activity and, in one of them, some sharp waveforms. Rhythmic slow waves, consistent with a subcortical origin, were found in four of the five patients with prominent changes. Examples of these four types of abnormality, together with a tracing from one of the less abnormal group, are shown in Fig. 1 . These findings were used to subdivide the patients into two groups, those with or without marked EEG abnormalities, which were compared. Of the four patientswith less abnormalrecords, three showed irregular slow activity, consistent with a cortical origin, but none showed evidenceof subcortical episodes. 
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Fl-13 group was compared in turn with the rest of the patients, the serum and RBC aluminium levels were found to be similar.In the wholepatientgrouptherewasno relationship between serum or RBC aluminium levels and estimated general intelligence.
Discussion
We have confirmed the presence of raised bromine levels in patients on long-term lithium treatment, both in the serum and in RBCs. These raised bromine levelscorrelated with dosage of lithium and with levels of lithium attained in the serum and RBCs. Thus it appears that lithium treatment closely affects endogenous bromine levels. In view of the above, it is of interest that serum bromine related to retrospective measures of the long-term effectiveness of lithium treatment, and serum lithium levels did not. This finding supports the suggestion of Handorf eta! (1985) that a rise in endogenous bromine could contribute to the thera peutic effects of lithium. It is interesting that point readings of bromine could relate so well to relapse over a prolonged period, in a relatively small group of patients. Point bromine levels may, therefore, have reflected its mean level over the years, despite possible variations with dose of lithium and dietary intake. We were able to confirm our findings in a prospective study of relapse, which showed a lower endogenous serum bromine level in relapsing patients than in non-relapsing patients. These findings appear worthy of further neurochemical study. Lithium activates the gamma-aminobutyric acid (GABA) system (Hetmar & Nielsen, 1988), and it is possible that bromine enhances the effects of lithium by itself augmenting GABA-ergic functions. Bromine may have this effect by increasing the function of chloride channels linked with GABA and benzodiazepine receptors (Placios et a!, 1979) .
The levels of bromine found in the present study are within the lower range of those relating to EEG abnormalities in methyl-bromide workers in the earliest stages of bromine intoxication. Verberk et a!(1979) found a geometric mean whole-blood bromine level of l0.9@ig/ml (meanÂ±s.d. 6.2â€"19.2@tg/ml) in their group with abnormal EEGs. By comparison, bromine used for medicinal purposes was allowed to build up to considerably higher levels, pro ducing marked toxic effects which were recognised in some patients at a whole-blood level of 500 @ag/ml, although six times this level was used by some clinicians and considered not to produce bromism For the entire patient group the dose of lithium, serum lithium concentration, RBC lithium and duration of lithium treatment were correlated with serum bromine and RBC bromine (Table 2) , the results suggesting that raised bromine levels are dependent on the amount of lithium ingested.
Among the nine patients still taking lithium at the time the blood specimens were taken, serum bromine was negatively relatedto the numberof relapseswhile on lithium, assessed retrospectively, (r= â€"¿ 0.782, two-tailed P<0.007).
To eliminatetreatmentselectionbias, weusedthe relative Levels of aluminium in RBCs are rarely reported, and normative data from dialysis patients were all that were available to us, on which to base our preliminary impressions. In the present study, however, we found aluminium RBC:serum ratios higher than in dialysis patients, not only in the lithium treatment group but also in the normal controls. The lower ratio in renal patients is possibly due to some effect from their higher aluminium levels, or differences in their blood chemistry. Thus lithium treatment was not found to cause any problem with excessive RBC aluminium uptake or raised blood levels. Also, with regard to possible (Cook et a!, 1986 ). We do not have tomographic data on our patients, although we have noted that the incidence of family history of affective disorder was similar in patients with or without major EEG abnormalities. The factors promoting EEG abnormalities are doubtless of multifactorial aetiology.
Our EEG findings are tentative, owing to the use of a number of statistical tests in small groups of patients. However, they form a unique pilot study of the neurophysiologically detectable effects of changes in the levels of trace elements F during lithium therapy. This is of particular relevance owing to the relation of endogenous bromine to relapse of affective disorder. Although EEG abnormalities were unassociated with lithium levels in serum and RBCs, we found higher levels of bromine and vanadium in a small group of patients showing irregular cortical activity on the EEG. This suggests that the long-term EEG effects of lithium may be mediated, to some extent, through its effects on other trace elements. However, these EEG changes were found in patients who did not have markedly abnormal tracings, so that whatever effects bromine and vanadium may have, appear to be of a limited nature.
